Cancer Pain Management Market Overview by Business Growth and Opportunities, Top Companies Profiles Pfizer Inc., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Johnson & Johnson Inc., Endo Pharmaceuticals, Eli Lilly Company, BioDelivery Sciences, Pro
The Global Cancer Pain Management Market Size is gaining traction owning to the factors such as ongoing research and development for developing new drugs, and rising number of patients suffering from cancer.
National Cancer Institute estimates approximately 5,80,350 Americans die from cancer. Cancer is the second leading cause of mortality in the U.S. which accounts for 1 in every 4 deaths. Pain is one of the most apprehended symptom in cancer. Despite greater availability of pain medications, it is often under-treated in the cancer patients. The pain observed due to growing tumour that destroys nearby tissues, press nerves, bones and organs. In some cases, the tumours cause pain as they release chemicals which harm the internal body parts. Cancer pain is a temporarily changing symptom that involves inflammatory, neuropathic, compression, and ischemic mechanisms. Cancer pain is categorized as chronic and acute pain which is distinct onset, and has prolonged effect. Chronic pain is also characterised by pain flares which is also termed as breakthrough pain.
Moreover, cancer pain is caused due to various cancer treatments procedures such as Surgical Pain, Phantom Pain, Procedure and Testing, and chemotherapy & radiation treatment. Cancer pain can be controlled by various pain relievers, like opioid, anti-inflammatory drugs, antidepressant, anti-seizers drugs and steroids.
Increasing launch of new drug development as a novel treatment of cancer pain will drive growth in the cancer pain management market.
The cancer pain market is primarily driven by rising prevalence of cancer worldwide. According to WHO, cancer is the second leading cause of death in North America, and was responsible for 8.8 million deaths in 2015. Additionally, National Cancer Institute estimated 1,685,210 new cases in the U.S. suffering from cancer in 2016. Similarly, various ongoing technological advancements for reducing pain caused due to surgical process would also influence the growth of this market. Moreover, the easy availability of the drugs that are used as painkiller would also propel the cancer pain management market.
However, side effects associated with the use of drugs that are used as a preferred treatment for cancer pain, and lack of awareness for using new technology for the pain treatment can hinder the market growth.
Global Cancer Pain Management Market Taxonomy
The cancer pain market is segmented on the basis of pain, drugs, route, treatment, and geography.
On the basis of pain type, global cancer pain management market size is segmented as;
• Acute Pain
• Chronic Pain
On the basis of drug type, global cancer pain management market share is segmented as;
• Non-steroidal anti-inflammatory drug
On the basis of application type, global cancer pain management market size is segmented as;
• Home Therapy
On the basis of end use type, global cancer pain management market share is segmented as;
• Cancer Care Clinics
Geographically, the global cancer pain management market size is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
High number of leading manufacturers in North America to boost cancer pain management market in this region.
On the basis of geography, North America is expected to dominate the global cancer pain market share over forecast period. The primary factors influencing growth of cancer pain management market in this region are continuous efforts for new product development by the manufacturers, high number of patients suffering for cancer, and enhanced healthcare expenditure by the individuals and the government. While, Europe holds the second largest share in cancer pain management market owing to improved medical infrastructure for treating cancer pain. Also, there is a rising trend of consolidation between manufacturers for tapping this growing market.
Asia Pacific cancer pain management market is projected to witness lucrative market growth in the forecast period owning to the, increasing awareness for the use of various therapies as the treatment of cancer pain.
Download FREE PDF Brochure @ http://bit.ly/2Pxy2gY
Key players in the global cancer pain management market are:
• Pfizer Inc.
• Mallinckrodt Pharmaceuticals
• Teva Pharmaceuticals
• Johnson & Johnson Inc.
• Endo Pharmaceuticals
• Eli Lilly & Company
• BioDelivery Sciences
• Prostrakan Group
• Sanofi S.A.
• Meda Pharmaceuticals
• Grunenthal Group
• Daiichi Sankyo
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Corporate Sales, USA
Polaris Market Research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Pain Management Market Overview by Business Growth and Opportunities, Top Companies Profiles Pfizer Inc., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Johnson & Johnson Inc., Endo Pharmaceuticals, Eli Lilly Company, BioDelivery Sciences, Pro here
News-ID: 1347970 • Views: 1021
More Releases from Polaris Market Research & Consulting
What's driving the Blockchain Technology Market Trends? Microsoft Corporation, I …
The worldwide market size for blockchain technology is estimated to grow at a CAGR of 41.6% between 2018 and 2026 and is anticipated to reach USD 16.82 billion by 2026. According to a new study published by Polaris Market Research. Also termed as Distributed Ledger Technology (DLT), blockchain enables secure transaction over a distributed network. Since the transactions are taken place usually over the network, it is difficult to reverse
What's driving the Precision Farming Market Trends? Ag Leader Technology, AgJunc …
The global precision farming/agriculture market was valued at 3,833 million in 2017 and is anticipated to reach over USD 13,016 million by 2026 with grow at a CAGR of more than 14.7% during the forecast period According to a new study published by Polaris Market Research. In 2017, the yield monitoring application dominated the global market, in terms of revenue. North America is expected to be the leading contributor to
What are the different trends in Electric Vehicles (EV) Market to boost its grow …
Polaris Market Research has new report published the addition of the “The global Electric Vehicles Market Worth $912 Billion By 2026 | CAGR: 38.4%”, the report classifies the global Electric Vehicles market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth Get PDF Sample of “Electric Vehicles Market”: https://www.polarismarketresearch.com/industry-analysis/electric-vehicles-ev-market/request-for-sample The global electric vehicles market is anticipated to
What are the different trends in Third Party Logistics Market to boost its growt …
Polaris Market Research has new report published the addition of the “The global third-party logistics market is anticipated to reach USD 1,337.91 billion by 2026”, the report classifies the global third-party logistics market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth according to a new report The report “Third Party Logistics (3PL) Market Share, Size,
More Releases for Cancer
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and